鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/02 | 3,400 | 3,465 | 3,400 | 3,455 | +45 | +1.3% | 23,000 |
| 2023/06/01 | 3,430 | 3,515 | 3,395 | 3,410 | +35 | +1% | 63,900 |
| 2023/05/31 | 3,425 | 3,445 | 3,350 | 3,375 | -80 | -2.3% | 99,600 |
| 2023/05/30 | 3,365 | 3,475 | 3,330 | 3,455 | +110 | +3.3% | 82,000 |
| 2023/05/29 | 3,445 | 3,445 | 3,340 | 3,345 | -40 | -1.2% | 13,800 |
| 2023/05/26 | 3,405 | 3,425 | 3,380 | 3,385 | -20 | -0.6% | 19,100 |
| 2023/05/25 | 3,480 | 3,480 | 3,400 | 3,405 | -75 | -2.2% | 21,500 |
| 2023/05/24 | 3,480 | 3,485 | 3,470 | 3,480 | ±0 | ±0% | 24,800 |
| 2023/05/23 | 3,490 | 3,500 | 3,445 | 3,480 | +10 | +0.3% | 32,500 |
| 2023/05/22 | 3,445 | 3,495 | 3,445 | 3,470 | +5 | +0.1% | 15,400 |
| 2023/05/19 | 3,440 | 3,480 | 3,440 | 3,465 | +25 | +0.7% | 23,100 |
| 2023/05/18 | 3,470 | 3,485 | 3,430 | 3,440 | +15 | +0.4% | 25,800 |
| 2023/05/17 | 3,485 | 3,490 | 3,425 | 3,425 | -65 | -1.9% | 29,300 |
| 2023/05/16 | 3,530 | 3,535 | 3,475 | 3,490 | -40 | -1.1% | 24,000 |
| 2023/05/15 | 3,490 | 3,545 | 3,490 | 3,530 | +55 | +1.6% | 31,100 |
| 2023/05/12 | 3,445 | 3,535 | 3,440 | 3,475 | +100 | +3% | 93,400 |
| 2023/05/11 | 3,355 | 3,390 | 3,350 | 3,375 | +20 | +0.6% | 20,500 |
| 2023/05/10 | 3,380 | 3,410 | 3,345 | 3,355 | -25 | -0.7% | 36,800 |
| 2023/05/09 | 3,330 | 3,385 | 3,330 | 3,380 | +85 | +2.6% | 42,400 |
| 2023/05/08 | 3,275 | 3,360 | 3,275 | 3,295 | -5 | -0.2% | 53,500 |
| 2023/05/02 | 3,350 | 3,365 | 3,285 | 3,300 | -45 | -1.3% | 37,800 |
| 2023/05/01 | 3,305 | 3,390 | 3,300 | 3,345 | -100 | -2.9% | 65,400 |
| 2023/04/28 | 3,445 | 3,515 | 3,415 | 3,445 | +50 | +1.5% | 91,400 |
| 2023/04/27 | 3,405 | 3,435 | 3,385 | 3,395 | +10 | +0.3% | 26,400 |
| 2023/04/26 | 3,400 | 3,430 | 3,380 | 3,385 | -5 | -0.1% | 39,800 |
| 2023/04/25 | 3,355 | 3,430 | 3,355 | 3,390 | +45 | +1.3% | 58,900 |
| 2023/04/24 | 3,375 | 3,375 | 3,330 | 3,345 | -5 | -0.1% | 39,500 |
| 2023/04/21 | 3,285 | 3,370 | 3,275 | 3,350 | +65 | +2% | 77,300 |
| 2023/04/20 | 3,270 | 3,290 | 3,250 | 3,285 | +50 | +1.5% | 53,500 |
| 2023/04/19 | 3,235 | 3,255 | 3,220 | 3,235 | -35 | -1.1% | 17,600 |
| 2023/04/18 | 3,280 | 3,295 | 3,260 | 3,270 | ±0 | ±0% | 15,300 |
| 2023/04/17 | 3,300 | 3,300 | 3,255 | 3,270 | -5 | -0.2% | 23,000 |
| 2023/04/14 | 3,250 | 3,280 | 3,240 | 3,275 | +35 | +1.1% | 33,900 |
| 2023/04/13 | 3,260 | 3,265 | 3,225 | 3,240 | -10 | -0.3% | 32,300 |
| 2023/04/12 | 3,240 | 3,260 | 3,225 | 3,250 | +15 | +0.5% | 32,600 |
| 2023/04/11 | 3,225 | 3,250 | 3,185 | 3,235 | +10 | +0.3% | 33,200 |
| 2023/04/10 | 3,195 | 3,225 | 3,185 | 3,225 | +30 | +0.9% | 21,700 |
| 2023/04/07 | 3,160 | 3,195 | 3,160 | 3,195 | +40 | +1.3% | 17,600 |
| 2023/04/06 | 3,115 | 3,160 | 3,110 | 3,155 | -10 | -0.3% | 29,300 |
| 2023/04/05 | 3,240 | 3,245 | 3,165 | 3,165 | -130 | -3.9% | 35,400 |
| 2023/04/04 | 3,205 | 3,325 | 3,200 | 3,295 | +125 | +3.9% | 65,500 |
| 2023/04/03 | 3,190 | 3,205 | 3,155 | 3,170 | -10 | -0.3% | 19,400 |
| 2023/03/31 | 3,165 | 3,190 | 3,165 | 3,180 | +35 | +1.1% | 27,100 |
| 2023/03/30 | 3,170 | 3,180 | 3,135 | 3,145 | -10 | -0.3% | 23,600 |
| 2023/03/29 | 3,130 | 3,160 | 3,125 | 3,155 | +55 | +1.8% | 39,800 |
| 2023/03/28 | 3,070 | 3,125 | 3,070 | 3,100 | +30 | +1% | 36,000 |
| 2023/03/27 | 3,070 | 3,085 | 3,055 | 3,070 | +10 | +0.3% | 12,000 |
| 2023/03/24 | 3,015 | 3,065 | 3,015 | 3,060 | +5 | +0.2% | 14,800 |
| 2023/03/23 | 3,075 | 3,075 | 3,030 | 3,055 | -25 | -0.8% | 24,200 |
| 2023/03/22 | 3,105 | 3,135 | 3,070 | 3,080 | +5 | +0.2% | 27,600 |
451～
500
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 420,500円 | +7.1% | -35.0% | 2.85% | 34.77倍 | 0.98倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 367,000円 | +14.5% | -2.3% | 2.45% | 13.43倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 237,900円 | +15.0% | -7.3% | 2.94% | 7.80倍 | 0.73倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 214,400円 | +14.2% | +41.0% | 2.15% | 10.50倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 142,800円 | - | - | 0.00% | - | 66.14倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
